Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: ANTI-TAC THERAPY FOR UVEITIS [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Anti-Tac Therapy for uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-Tac Therapy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Uveitis | Phase 1 | Status: COMPLETED